INCY
Incyte Genomics Inc ยท Industrials ยท NASDAQ
$103.66
โฒ $5.44 (+5.54%)
Market cap
$19.6B
52-week range
$66.74 โ $112.29
Volume
2.2M
Previous close
$98.22
Incyte Genomics Inc (INCY) is held by 5 tracked hedge fund(s) and traded by 1 member(s) of Congress. Sector: Industrials. Largest tracked holder: BAKER BROS. ADVISORS LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
16.6% | 30.7M | $2.9B | โ | $72.27 | 2026-03-31 |
| AQR Capital Management Cliff Asness |
0.3% | 6.7M | $664M | โผ 15% (โ1.2M) | $79.19 | 2025-12-31 |
| Renaissance Technologies Jim Simons |
0.6% | 4.0M | $393M | โผ 12% (โ550K) | $0.08 | 2025-12-31 |
| AustralianSuper Pty Ltd AustralianSuper Pty Ltd |
0.6% | 1.1M | $107M | โฒ 77% (+496K) | $72.27 | 2026-03-31 |
| ARMISTICE CAPITAL, LLC ARMISTICE CAPITAL, LLC |
1.1% | 657K | $62M | โผ 40% (โ441K) | $72.27 | 2026-03-31 |
FAQ โพ
Which hedge funds hold INCY?
Tracked holders include: BAKER BROS. ADVISORS LP, AQR Capital Management, Renaissance Technologies, AustralianSuper Pty Ltd.
How much smart money owns INCY?
5 tracked hedge fund(s) and 1 member(s) of Congress have disclosed positions.
Are members of Congress trading INCY?
Yes โ 1 member(s) have disclosed INCY trades. See the Congress tab.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.